Literature DB >> 26961948

Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Joseph W Goodliffe1, Jose Luis Olmos-Serrano1, Nadine M Aziz1, Jeroen L A Pennings2, Faycal Guedj3, Diana W Bianchi3, Tarik F Haydar4.   

Abstract

Studies in humans with Down syndrome (DS) show that alterations in fetal brain development are followed by postnatal deficits in neuronal numbers, synaptic plasticity, and cognitive and motor function. This same progression is replicated in several mouse models of DS. Dp(16)1Yey/+ (hereafter called Dp16) is a recently developed mouse model of DS in which the entire region of mouse chromosome 16 that is homologous to human chromosome 21 has been triplicated. As such, Dp16 mice may more closely reproduce neurodevelopmental changes occurring in humans with DS. Here, we present the first comprehensive cellular and behavioral study of the Dp16 forebrain from embryonic to adult stages. Unexpectedly, our results demonstrate that Dp16 mice do not have prenatal brain defects previously reported in human fetal neocortex and in the developing forebrains of other mouse models, including microcephaly, reduced neurogenesis, and abnormal cell proliferation. Nevertheless, we found impairments in postnatal developmental milestones, fewer inhibitory forebrain neurons, and deficits in motor and cognitive performance in Dp16 mice. Therefore, although this new model does not express prenatal morphological phenotypes associated with DS, abnormalities in the postnatal period appear sufficient to produce significant cognitive deficits in Dp16.
Copyright © 2016 the authors 0270-6474/16/362926-19$15.00/0.

Entities:  

Keywords:  cognition; developmental milestones; embryonic development; trisomy 21

Mesh:

Substances:

Year:  2016        PMID: 26961948      PMCID: PMC4783496          DOI: 10.1523/JNEUROSCI.2513-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  The neurobiological basis of spontaneous alternation.

Authors:  Robert Lalonde
Journal:  Neurosci Biobehav Rev       Date:  2002-01       Impact factor: 8.989

Review 2.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

3.  Developmental milestones in toddlers with atypical development.

Authors:  Max Horovitz; Johnny L Matson
Journal:  Res Dev Disabil       Date:  2011-08-19

4.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

Authors:  C M P O'Tuathaigh; D Babovic; G J O'Sullivan; J J Clifford; O Tighe; D T Croke; R Harvey; J L Waddington
Journal:  Neuroscience       Date:  2007-05-21       Impact factor: 3.590

6.  Multiplex genetic fate mapping reveals a novel route of neocortical neurogenesis, which is altered in the Ts65Dn mouse model of Down syndrome.

Authors:  William A Tyler; Tarik F Haydar
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

7.  Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).

Authors:  Alberto C S Costa; Melissa R Stasko; Cecilia Schmidt; Muriel T Davisson
Journal:  Behav Brain Res       Date:  2009-08-29       Impact factor: 3.332

8.  Prevention of developmental delays in a Down syndrome mouse model.

Authors:  Laura Toso; Irene Cameroni; Robin Roberson; Daniel Abebe; Stephanie Bissell; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.623

9.  What is the Most Sensitive Measure of Water Maze Probe Test Performance?

Authors:  Hamid R Maei; Kirill Zaslavsky; Cátia M Teixeira; Paul W Frankland
Journal:  Front Integr Neurosci       Date:  2009-03-09

Review 10.  Hippocampal-prefrontal circuit and disrupted functional connectivity in psychiatric and neurodegenerative disorders.

Authors:  Ming Li; Cheng Long; Li Yang
Journal:  Biomed Res Int       Date:  2015-04-01       Impact factor: 3.411

View more
  24 in total

1.  Early impacts of modified food consistency on oromotor outcomes in mouse models of Down syndrome.

Authors:  Tiffany J Glass; Sara L Twadell; Luke C Valmadrid; Nadine P Connor
Journal:  Physiol Behav       Date:  2018-11-26

Review 2.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

Review 3.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

4.  Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome).

Authors:  Kirby M Sherman; Diarra K Williams; Casey A Welsh; Alexis M Cooper; Alyssa Falck; Shannon Huggins; Rihana S Bokhari; Dana Gaddy; Kent D McKelvey; Lindsay A Dawson; Larry J Suva
Journal:  Bone       Date:  2022-06-15       Impact factor: 4.626

5.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

6.  Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.

Authors:  Mariko Sawa; Cassia Overk; Ann Becker; Dominique Derse; Ricardo Albay; Kim Weldy; Ahmad Salehi; Thomas G Beach; Eric Doran; Elizabeth Head; Y Eugene Yu; William C Mobley
Journal:  Alzheimers Dement       Date:  2021-11-10       Impact factor: 16.655

7.  Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.

Authors:  Nadine M Aziz; Faycal Guedj; Jeroen L A Pennings; Jose Luis Olmos-Serrano; Ashley Siegel; Tarik F Haydar; Diana W Bianchi
Journal:  Dis Model Mech       Date:  2018-06-12       Impact factor: 5.758

8.  Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.

Authors:  April D Adams; Victoria Hoffmann; Laura Koehly; Faycal Guedj; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2021-03-22       Impact factor: 10.693

9.  An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.

Authors:  Faycal Guedj; Jeroen LA Pennings; Lauren J Massingham; Heather C Wick; Ashley E Siegel; Umadevi Tantravahi; Diana W Bianchi
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

10.  Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development.

Authors:  Millie A Ferrés; Diana W Bianchi; Ashley E Siegel; Roderick T Bronson; Gordon S Huggins; Faycal Guedj
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.